EMA starts rolling review for Sputnik V vaccine

EMA’s human medicines committee has started a rolling review of Sputnik V, a COVID-19 vaccine developed by Russia’s Gamaleya National Centre of Epidemiology and Microbiology.

Read more

CAC builds biofuel plant for OMV

Chemieanlagenbau Chemnitz (CAC) is realizing one of the first large-scale plants in Europe to use innovative co-processing to produce carbon-neutral fuels.

Read more

French biotech investors launch spin-out alliance

Kurma Parnters and France‘e investment bank have launched a €50m project named Argobio that is aimed at identifiying the most genious biotech ideas and spin out companies.

Read more

Oxular Ltd raises US$37m

British Oxular Ltd has raised $37m in a financing round led by Forbion Parners and co-financed by IP Group, NeoMed, and V-Bio Ventures to push its pipeline.

Read more

MosaMeat BV closes US$85m Series B financing

Cultured meat producer MosaMeat BV has announced the third and final closing of its Series B round raising US$85m.

Read more

Biomarker identifies high-risk COVID-19 patients

Austrian researchers have found that a lack of activation of the NK receptor is highly associated with severe COVID-19 disease courses.

Read more

EU orders additional COVID-19 vaccine doses

Pfizer Inc. and BioNTech SE have signed an agreement with the European Commission (EC) to supply an additional 200 million doses of BNT162b2 to the EU.

Read more